Gilead Sciences
GILD
#129
Rank
โ‚ฌ129.18 B
Marketcap
104,12ย โ‚ฌ
Share price
-1.14%
Change (1 day)
22.10%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ31.84 Billion

According to Gilead Sciences's latest financial reports the company's total liabilities are โ‚ฌ31.84 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ38.19 B7.24%
2023-12-31โ‚ฌ35.61 B-8.95%
2022-12-31โ‚ฌ39.11 B-5.51%
2021-12-31โ‚ฌ41.40 B1.47%
2020-12-31โ‚ฌ40.80 B17.27%
2019-12-31โ‚ฌ34.79 B-5.55%
2018-12-31โ‚ฌ36.83 B-11.22%
2017-12-31โ‚ฌ41.49 B16.02%
2016-12-31โ‚ฌ35.75 B19.93%
2015-12-31โ‚ฌ29.81 B92.44%
2014-12-31โ‚ฌ15.49 B97.51%
2013-12-31โ‚ฌ7.84 B-11.28%
2012-12-31โ‚ฌ8.84 B10.03%
2011-12-31โ‚ฌ8.03 B95.38%
2010-12-31โ‚ฌ4.11 B84.53%
2009-12-31โ‚ฌ2.22 B26.09%
2008-12-31โ‚ฌ1.76 B15.51%
2007-12-31โ‚ฌ1.53 B-8.93%
2006-12-31โ‚ฌ1.68 B169.52%
2005-12-31โ‚ฌ0.62 B196.65%
2004-12-31โ‚ฌ0.21 B-52.04%
2003-12-31โ‚ฌ0.43 B-36.09%
2002-12-31โ‚ฌ0.68 B76.9%
2001-12-31โ‚ฌ0.38 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚ฌ69.16 B 117.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ6.47 B-79.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ117.23 B 268.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ3.26 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.44 B-70.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 211.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 206.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ78.23 B 145.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.68 B 109.40%๐Ÿ‡บ๐Ÿ‡ธ USA